Medtronic (NYSE: MDT) reported Q1 EPS of $1.13, $0.01 better than the analyst estimate of $1.12. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.22 billion.

GUIDANCE:

Medtronic sees FY2023 EPS of $5.53-$5.65, versus the consensus of $5.56.

For earnings history and earnings-related data on Medtronic (MDT) click here.